Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2020

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the reconciliation of the numerator and the denominator of basic and diluted loss per share for the three and nine months ended September 30, 2020 and 2019 (dollars in thousands, except per share amounts):


	Three Months Ended September 30, 2020		Three Months Ended September 29, 2019		Nine Months Ended September 30, 2020		Nine Months Ended September 29, 2019
Numerator:
Net (loss)	$	980	$	(1,264)	$	(4,473)	$	(9,077)
Denominator:
Weighted average shares outstanding, basic	9,779,147		9,779,147		9,779,147		9,779,147
Dilutive effect of stock-based awards	48,197		—		—		—
Weighted average share outstanding, diluted	9,827,344		9,779,147		9,779,147		9,779,147

Basic loss per share	$	0.10	$	(0.13)	$	(0.46)	$	(0.93)
Diluted loss per share	$	0.10	$	(0.13)	$	(0.46)	$	(0.93)

Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share

A summary of these anti-dilutive common stock equivalents is provided in the table below:


	Nine Months Ended September 30, 2020	Nine Months Ended September 29, 2019
Number of options	698,980	593,680
Exercise price of options	$2.36 - $12.58	$7.65 - $12.58
Warrants(1)		142,185
Exercise price of warrants		$3.33 - $11.88

_________________________________

(1) Includes warrants to purchase 141,000 shares of common stock issued to the underwriters of the Company's IPO in July 2015 with an exercise price of $11.88 per share of common stock which expired on July 7, 2020.